- Home
- TAP vs QGEN Comparison
TAP vs QGEN Comparison
Compare TAP & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAP
- QGEN
- Stock Information
- Founded
- TAP 1873
- QGEN 1986
- Country
- TAP United States
- QGEN Netherlands
- Employees
- TAP N/A
- QGEN N/A
- Industry
- TAP Beverages (Production/Distribution)
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TAP Consumer Staples
- QGEN Health Care
- Exchange
- TAP Nasdaq
- QGEN Nasdaq
- Market Cap
- TAP 10.1B
- QGEN 10.7B
- IPO Year
- TAP N/A
- QGEN 1996
- Fundamental
- Price
- TAP $43.36
- QGEN $45.74
- Analyst Decision
- TAP Hold
- QGEN Buy
- Analyst Count
- TAP 14
- QGEN 7
- Target Price
- TAP $53.43
- QGEN $50.68
- AVG Volume (30 Days)
- TAP 2.1M
- QGEN 957.4K
- Earning Date
- TAP 11-04-2025
- QGEN 11-04-2025
- Dividend Yield
- TAP 4.30%
- QGEN 3.22%
- EPS Growth
- TAP N/A
- QGEN 405.09
- EPS
- TAP 5.06
- QGEN 1.69
- Revenue
- TAP $11,283,200,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- TAP N/A
- QGEN $7.37
- Revenue Next Year
- TAP $0.55
- QGEN $5.65
- P/E Ratio
- TAP $8.64
- QGEN $27.67
- Revenue Growth
- TAP N/A
- QGEN 5.15
- 52 Week Low
- TAP $42.94
- QGEN $37.63
- 52 Week High
- TAP $64.66
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- TAP 30.17
- QGEN 38.32
- Support Level
- TAP $42.94
- QGEN $48.34
- Resistance Level
- TAP $47.24
- QGEN $49.53
- Average True Range (ATR)
- TAP 0.89
- QGEN 0.82
- MACD
- TAP -0.25
- QGEN -0.30
- Stochastic Oscillator
- TAP 9.17
- QGEN 10.05
About TAP Molson Coors Beverage Company Class B
Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the US, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the US, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).